Eric F. Tewalt, PhD

Director
PPD, part of Thermo Fisher Scientific
Richmond, Virginia, United States

Dr. Eric Tewalt serves as Director in the Immunochemistry Department of the Bioanalytical Labs in the Clinical Research Group at PPD, part of Thermo Fisher Scientific. He oversees a team focused on oligonucleotide and nucleic-acid modalities, and gene therapy modalities, that conducts method development, validation and bioanalysis of immunogenicity, pharmacokinetic, and regulated biomarker samples in support of pre-clinical and clinical trials in a regulated environment. Dr. Tewalt has over ten years of experience in the bioanalytical field and an additional 9 years of experience in immunology, infectious disease, and cancer research and has extensive knowledge in assay and experimental design.

Disclosure information not submitted.

Presentation(s):

• Hot Topic: Bioanalytical Challenges and Strategies for Novel Drug Modalities

  Wednesday, April 26, 2023
  10:00 AM – 11:00 AM ET